Top 5 US FDA 510(k) Consultants in India 2026 | MedRegX

The US Food and Drug Administration (FDA) — the federal agency responsible for regulating medical devices sold in the United States — requires most Class II devices, and some Class I and Class III devices, to clear a Premarket Notification, commonly known as a 510(k), before they can legally enter the US market. For Indian medical device manufacturers targeting the world's largest single medical device market, a 510(k) clearance is often the difference between a device that stays domestic and one that scales globally, which makes selecting the right US FDA 510(k) certification consultant in India a decision with real commercial consequences.

This guide explains what the 510(k) pathway actually involves, walks through the submission process step by step, and compares the leading US FDA 510(k) consultants in India for 2026 — including MedRegX — based on independently verified information about each firm's service scope. For related FDA requirements, see our guides on US FDA product listing, FDA 510(k) submission, and the FDA accession number assigned once your submission is received.

What is US FDA 510(k) certification, and who needs it?

A 510(k) is a premarket submission made to the US FDA to demonstrate that a medical device is "substantially equivalent" to a legally marketed predicate device, and clearance is required before most Class II devices can be sold in the United States. The submission doesn't prove a device is inherently safe in isolation — it proves the device is at least as safe and effective as a comparable device the FDA has already reviewed and cleared.

Any Indian manufacturer or exporter intending to sell a Class II device — and some Class I and Class III devices — into the US market needs 510(k) clearance, regardless of whether the device already holds a CDSCO licence or CE mark. Before a company can submit a 510(k), it must also complete US FDA product listing and establishment registration, and every submission received is assigned an FDA accession number used to track the review from that point forward.

What does a US FDA 510(k) consultant actually do?

A US FDA 510(k) consultant manages the submission process end-to-end — predicate device identification, substantial equivalence analysis, technical file preparation, eSTAR submission, and FDA query response — on behalf of a manufacturer or exporter. Engaging one isn't a legal requirement, but predicate selection and substantial equivalence arguments are technically demanding, and a weak predicate choice is one of the most common reasons an FDA reviewer issues an Additional Information (AI) request that can add months to the timeline.

For an Indian manufacturer, this typically also includes coordinating a US Agent — a US-based point of contact the FDA requires for any foreign establishment — and aligning the device's existing ISO 13485 quality management system documentation with FDA's Quality System Regulation (QSR) expectations under 21 CFR Part 820, since gaps here are a frequent source of delay for first-time applicants.

Documents required for a 510(k) submission

A complete 510(k) submission needs device description, predicate comparison, performance data, and administrative documentation — the eSTAR template organises these into a standard 21-section structure.

How the US FDA 510(k) process works: step-by-step

The 510(k) pathway runs through six stages — classification and predicate selection, testing, technical file preparation, eSTAR submission, FDA review and query response, and clearance — typically taking three to twelve months depending on device complexity.

Common pitfalls in 510(k) submissions

Most 510(k) delays trace back to a small set of recurring errors — a weak predicate comparison carries the highest risk, since it can trigger a Not Substantially Equivalent (NSE) decision.

What does a 510(k) certification cost for an Indian manufacturer?

Total 510(k) cost for most manufacturers ranges from roughly $50,000 to $250,000 or more, combining the FDA user fee, performance testing, and consultant fees — the FDA fee itself is usually the smallest part of the total. The FY2026 standard user fee is $26,067, reduced to $6,517 for businesses qualifying under the FDA's Small Business Determination Program, but device testing — particularly biocompatibility and sterilization validation for invasive or implantable devices — is typically the largest single cost driver.

Consultant fees are generally quoted separately and vary with device complexity, ranging from a defined project fee for a straightforward Class II device to a substantially higher scope for software-driven or implantable devices requiring extensive clinical or cybersecurity documentation. Because scope varies so much by device type, request a written, itemised quote after the consultant has reviewed your specific product and proposed predicate — and treat any all-inclusive flat quote given before a predicate has even been identified with some scepticism.

510(k) vs De Novo vs PMA: which US FDA pathway applies?

510(k), De Novo, and Premarket Approval (PMA) are the three main US FDA device pathways, and the one that applies depends on whether a comparable device already exists on the US market and how much risk the device carries. A 510(k) applies when a legally marketed predicate device exists and the new device can be shown to be substantially equivalent to it — this covers most Class II devices and is the fastest and least expensive of the three pathways.

De Novo classification applies to novel, low-to-moderate risk devices that have no existing predicate, allowing the FDA to create a new device classification rather than forcing an ill-fitting comparison to an unrelated predicate. PMA, the most rigorous pathway, applies to Class III devices — typically life-sustaining or implantable devices — and requires clinical data demonstrating safety and effectiveness rather than a substantial equivalence argument; the FY2026 PMA fee of $579,272 reflects that higher scrutiny. Most Indian manufacturers exporting general medical devices, diagnostic equipment, or surgical instruments to the US will fall under the 510(k) pathway, which is why it remains the most commonly sought FDA certification among Indian device exporters.

How to evaluate a US FDA 510(k) consultant in India

The strongest predictor of a smooth 510(k) review is a consultant's documented experience with your specific device category and product code — not general regulatory experience alone. A firm with a strong track record in diagnostic devices may have limited hands-on experience with orthopaedic implants, and predicate selection, testing requirements, and likely FDA questions differ substantially between device types.

Ask specifically how many 510(k) submissions the firm has taken through to clearance in your device category, not just how many countries or regulatory frameworks it lists as service offerings. Confirm whether the firm handles US Agent coordination directly or refers it to a third party, since a fragmented setup between separate consultants often slows FDA correspondence. Also check the firm's approach to Additional Information (AI) requests — since the interactive review clock restarts each time a response is submitted, how quickly and precisely a consultant responds to FDA queries has a direct, measurable effect on total time to clearance. Finally, request a written, itemised fee quote covering the FDA user fee, consultant fees, and any testing coordination separately, so you can compare firms on the same basis rather than against bundled headline numbers.

Top 5 US FDA 510(k) certification consultants in India (2026)

The consultants below are independently verifiable, operating firms with a documented US FDA 510(k) regulatory practice — not a self-reported ranking. Request references and a written scope of work from any firm you evaluate, MedRegX included.

This list reflects publicly available information on each firm's stated service scope as of 2026, not an independently audited performance ranking.

How MedRegX supports US FDA 510(k) certification, end-to-end

Choosing a US FDA 510(k) consultant in India comes down to verifiable predicate-selection experience and a track record of clean FDA query response — not marketing claims. Whether you're submitting your first 510(k) or expanding an existing US-cleared portfolio, confirm the firm's experience with your specific device category, its approach to US Agent coordination, and its written fee scope before signing with any consultant, including MedRegX. Getting the predicate and classification right at the outset is what keeps a 510(k) inside the FDA's 90-day review goal instead of stretching into a year.